Introduction of Chongqing Kerui Nanhai Pharmaceutical Co., Ltd
Chongqing Kerui Nanhai Pharmaceutical Co., Ltd is formerly known as Chongqing Nanhai Pharmaceutical Co., Ltd which had a share restructuring in 2008. Now Chongqing Kerui Nanhai Pharmaceutical Co., Ltd is a brand-new state-owned pharmaceutical company in which Chongqing Kerui Pharmaceutical Co., Ltd holdings and Chongqing Xinyu Investment Group shares. Both of the two companies belong to Chongqing Chemical& Pharmaceutical (Holding) Group.
Chongqing Kerui Nanhai Pharmaceutical Co., Ltd is located in the Zhengyang Industrial Park in Chongqing with plot area is 53,360 square meters, built-up area is more than 20,000 square meters, and the total assets is more than one hundred million. Our company, in the excellent surroundings, has advanced facilities and the first-class modern R&D, production and testing equipments, also has strict implementation of standard operating procedures. There are more than 200 employees in our company, and the engineering staff with college degree account for 45% of the total number of employees.
Our company has five modern standard production lines meet GMP standard: herb extraction, tablets, capsule, oral liquid and granule, with management of enterprises in strict accordance with GMP requirements, and was passed the National GMP re-certification in July 2009.In December 2009, resveratrol, Shensuo Baji oral liquid, guixiong pollen oral liquid, Metformin Hydrochloride Sustained-release tablet and Longqing capsule of the company, the five products were rated as high and new technology products of Chongqing, and our company was awarded the title of municipal leading enterprises in agriculture industrialization. Our company is a high-tech enterprise which is mainly engaged in developing and large-scaled producing natural herb extracts and pharmaceutical intermediates. Our company always sticks to three principles, firstly, sticking to "two combinations", they are: the combination of Scientific Research and Production, the combination of long-term planning and the recent development; secondly, sticking to "two services", they are: servicing for the development of Chinese medicine industry, servicing for the Chinese medicine production enterprises; thirdly, sticking to "two effects", they are: social effect and economic effects.
Now our company is one of the biggest producer and exporter in the aspect of herb extracts in China with more than 20 products. Shensuo Baji oral liquid and guixiong pollen oral liquid which are independently developed by us had got the national certificate of patent; Artemisinin and resveratrol have exported to other countries. The location of our company is nearby the largest GAP plant base of sweet wormwood in China. We can produce artemisinin with high quality (99.5%, HPLC) more than 30MT per year, and resveratrol (98%、50%)30MT and 60MT separately.
The great pass is supposed to be iron-hard; our troops stormed it over for a new start. Chongqing Kerui Nanhai Pharmaceutical Co., Ltd which has gone through a long and arduous journey will adhere to the company philosophy (kindheartedness goes to anywhere, love comes in every family) in the new journey, and will further promote the culture of Chinese medicine; cultivate and develop Chinese medicine industry; adhere to the style of being honest and professional; introduce the advanced management mode of modern enterprises; highlight the technology innovation, system innovation and management innovation; keep accelerating the progress of technology and innovation and achieve the aim that to get sales turnover up to two hundreds million during two or three years.
Chongqing Kerui Nanhai Pharmaceutical Co., Ltd will stand among the excellent enterprises of Chinese medicine and herb extraction with a new attitude.
Contact: 023-67797458
Yan Li 18696591855
Jaingqin Du 18696593566
(Herbridge Media)
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year

